Identifying, diagnosing and treating patients with later-onset SMA
Watch Dr Julie Parsons, a leading expert in spinal muscular atrophy (SMA), review the clinical presentation, diagnosis and management of later-onset phenotypes of SMA, including a review of key clinical trials for approved treatments and their impact on the natural history of SMA. View the full activity here: https://touchneurology.com/cme/later-... 🔸Don't forget to sign up to email alerts on our touchNEUROLOGY website to keep up to date with all news, topics and new activities available here: https://touchneurology.com/create-acc... 🔸You can also follow us on: Twitter: / touchneurology Facebook: / touchneurology Instagram: / touchneurology #Spinalmuscularatrophy #rarediseases #neuromusculardiseases #SMA

▶︎
Spinal Muscular Atrophy 2019: SMA Pathophysiology, Diagnosis and Clinical Presentations

▶︎
Maintaining quality of life in patients with later-onset SMA

▶︎
IgG4-RD and Treatment | IgG4ward! Fireside Chat

▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

▶︎
An Update on Spinal Muscular Atrophy Current Treatment Paradigms and Ongoing Research

▶︎
Understanding Retroperitoneal Fibrosis in IgG4-RD | Patient Stories, Diagnosis & Treatment Options

▶︎
Empowering Allied Health Professionals Through Education in Organ, Tissue and Cell Donation and...

▶︎
Breakthroughs in treating NSCLC: Targeting KRAS

▶︎
SMA Type 3 - Living with SMA PODCAST #14

▶︎
Spinal Muscular Atrophy (SMA) Research Update

▶︎
Evolving ART Switch Options Podcast

▶︎
The First IgG4-RD Patient Treated with B-Cell Therapy

▶︎
DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

▶︎
Spinal Muscular Atrophy | Mechanism & Presentation

▶︎
HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers

▶︎
Doddie Weir On Being Diagnosed With Motor Neuron Disease | Lorraine

▶︎
Myotonic Dystrophy Type 1: Disease Development & Symptom Management - 2023 MDF Annual Conference

▶︎
Spinal Muscular Atrophy 2019: Later Onset Spinal Muscular Atrophy

▶︎
HNSCC: Current and Emerging Therapeutic Strategies

▶︎
